KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $283.0 million.

  • Amgen's Other Working Capital Changes fell 535.12% to $283.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $704.0 million, marking a year-over-year decrease of 1908.05%. This contributed to the annual value of $652.0 million for FY2024, which is 1560.28% up from last year.
  • Per Amgen's latest filing, its Other Working Capital Changes stood at $283.0 million for Q3 2025, which was down 535.12% from $206.0 million recorded in Q2 2025.
  • In the past 5 years, Amgen's Other Working Capital Changes registered a high of $299.0 million during Q3 2024, and its lowest value of -$241.0 million during Q2 2022.
  • For the 5-year period, Amgen's Other Working Capital Changes averaged around $99.2 million, with its median value being $115.0 million (2021).
  • Per our database at Business Quant, Amgen's Other Working Capital Changes plummeted by 31517.86% in 2022 and then surged by 72187.5% in 2023.
  • Amgen's Other Working Capital Changes (Quarter) stood at -$136.0 million in 2021, then surged by 32.35% to -$92.0 million in 2022, then skyrocketed by 352.17% to $232.0 million in 2023, then plummeted by 93.97% to $14.0 million in 2024, then skyrocketed by 1921.43% to $283.0 million in 2025.
  • Its Other Working Capital Changes stands at $283.0 million for Q3 2025, versus $206.0 million for Q2 2025 and $201.0 million for Q1 2025.